Results 221 to 230 of about 843,559 (297)

Repurposing a Small Molecule Plant Hormone as a Tunable ON‐Switch for CAR‐T Cell Immunotherapy

open access: yesAdvanced Science, Volume 13, Issue 61, 3 November 2026.
By engineering a receptor system integrating the plant auxin receptor AFB1 with its co‐receptor IAA7, we enable ligand‐dependent interactions triggered by the plant hormone auxins. This design allows rapid, reversible, and dose‐dependent T cell activation, resulting in potent cytotoxicity against B‐cell lymphoma in vitro and in vivo.
Hongxiang Zeng   +16 more
wiley   +1 more source

CD20 bispecific T-cell engager depletes B-cell progenitors preventing EBV-associated lymphomagenesis in humanized mice. [PDF]

open access: yesBlood Adv
Böni M   +12 more
europepmc   +1 more source

A Drug‐Gated, Modular STAb‐T Immunotherapy With External Control

open access: yesAdvanced Science, Volume 13, Issue 61, 3 November 2026.
Engineered STAb‐TON cells act as programmable living factories that continuously secrete inactive antibody modules, which assemble extracellularly into a functional T cell engager only upon small‐molecule administration. This externally controlled platform enables reversible, on‐demand regulation of antitumor immunity, establishing a new paradigm for ...
Susana Luengo‐Arias   +23 more
wiley   +1 more source

Targeting circulating fatty acid-binding protein 4 ameliorates obesity-associated hepatic steatosis. [PDF]

open access: yesJHEP Rep
Jiang X   +16 more
europepmc   +1 more source

Overcoming Drug Resistance by Paclitaxel Resistance in Triple‐Negative Breast Cancer

open access: yesAdvanced Science, Volume 13, Issue 62, 9 November 2026.
In the murine triple‐negative breast cancer (TNBC) model, chemotherapy effectively increases tumor neoantigen burden (TNB). Here, the study constructs a liposomal nanovaccine using antigens derived from in vitro chemotherapy‐treated paclitaxel‐resistant TNBC 4T1 cells.
Bo Chen   +10 more
wiley   +1 more source

Non-PF4/heparin-binding, platelet-activating antibodies in heparin-induced thrombocytopenia. [PDF]

open access: yesBlood
Zhou L   +11 more
europepmc   +1 more source

AI‐Assisted Tumor Boundary Delineation via Targeted Ultrasmall Iron Oxide Nanoprobe for High‐Contrast HER2‐Positive Tumor Imaging

open access: yesAdvanced Science, Volume 13, Issue 63, 12 November 2026.
A novel targeted and pH‐responsive MRI contrast agent was integrated with a 3D nnU‐Net deep learning framework to enable accurate delineation of tumor boundary morphology in HER2‐positive breast cancer imaging. ABSTRACT Breast cancer continues to be a leading cause of cancer‐related mortality in women globally, where precise diagnosis and clear tumor ...
Jiaying Zheng   +7 more
wiley   +1 more source

TREM2 Signaling and Alzheimer's Disease: Experimental Modulators, Progress, and Challenges. [PDF]

open access: yesDrug Des Devel Ther
Sayegh M   +5 more
europepmc   +1 more source

Targeting CCR7 Attenuates Aggressive Phenotypes in Diffuse Large B‐Cell Lymphoma by Suppressing Wnt/β‐Catenin Signaling

open access: yesCancer Medicine, Volume 15, Issue 11, November 2026.
CCL21/CCR7 signaling activates the Wnt/β‐catenin pathway to promote invasion, migration, and survival of B‐cell lymphoma cells. Targeting CCR7 with CAP‐100 attenuates these malignant phenotypes. ABSTRACT Background The CCL21/CCR7 chemokine axis is implicated in lymphocyte trafficking and cancer metastasis, yet its specific role and molecular mechanism ...
Keke Huang   +15 more
wiley   +1 more source

Home - About - Disclaimer - Privacy